Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (271-280 of 669) with videos related to

Pageof 67
Sort By:
Oncology Reports|February 1, 2014
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cellsYue-Li Sun, Priyank Kumar, Kamlesh Sodani, et al.
Journal of Biomedical Research|March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletionJason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Cancer Letters|October 11, 2016
PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemiaPranav Gupta, Rishil J Kathawala, Liuya Wei, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 17, 2022
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspectsMaohua Huang, Yuning Lin, Chenran Wang, et al.
RSC Medicinal Chemistry|February 23, 2024
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistanceFei Cao, Yulong Li, Furong Ma, et al.
Frontiers in Pharmacology|July 3, 2026
Reversal of ABCG2-mediated MDR by VEGFR3 inhibitor (S)-SAR131675Xiang Chen, Jiaqian Xu, Ryan Li, et al.
Cancer Letters|December 23, 2008
RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletionYe-Hong Kuang, Xiang Chen, Juan Su, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 12, 2025
Dual-Functional Ag-ZnO Nanocomposite Interlayers Enable Robust Copper Metallization on NiFe<sub>2</sub>O<sub>4</sub> Substrates for High-Performance X-Band Ferrite Microstrip IsolatorsGuo-Liang Liu, Diwen Jiang, Li Wang, et al.
Pharmacology & Therapeutics|September 10, 2020
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19Zi-Ning Lei, Zhuo-Xun Wu, Shaowei Dong, et al.
Cancer Letters|November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivoAlbert A De Vera, Pranav Gupta, Zining Lei, et al.
Pageof 67

Showing results (271-280 of 669) with videos related to

Sort By:
Pageof 67
Oncology Reports|February 1, 2014
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cellsYue-Li Sun, Priyank Kumar, Kamlesh Sodani, et al.
Journal of Biomedical Research|March 10, 2017
Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletionJason D Whitt, Adam B Keeton, Bernard D Gary, et al.
Cancer Letters|October 11, 2016
PBA2, a novel inhibitor of imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemiaPranav Gupta, Rishil J Kathawala, Liuya Wei, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 17, 2022
New insights into antiangiogenic therapy resistance in cancer: Mechanisms and therapeutic aspectsMaohua Huang, Yuning Lin, Chenran Wang, et al.
RSC Medicinal Chemistry|February 23, 2024
Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistanceFei Cao, Yulong Li, Furong Ma, et al.
Frontiers in Pharmacology|July 3, 2026
Reversal of ABCG2-mediated MDR by VEGFR3 inhibitor (S)-SAR131675Xiang Chen, Jiaqian Xu, Ryan Li, et al.
Cancer Letters|December 23, 2008
RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletionYe-Hong Kuang, Xiang Chen, Juan Su, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 12, 2025
Dual-Functional Ag-ZnO Nanocomposite Interlayers Enable Robust Copper Metallization on NiFe<sub>2</sub>O<sub>4</sub> Substrates for High-Performance X-Band Ferrite Microstrip IsolatorsGuo-Liang Liu, Diwen Jiang, Li Wang, et al.
Pharmacology & Therapeutics|September 10, 2020
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19Zi-Ning Lei, Zhuo-Xun Wu, Shaowei Dong, et al.
Cancer Letters|November 5, 2018
Immuno-oncology agent IPI-549 is a modulator of P-glycoprotein (P-gp, MDR1, ABCB1)-mediated multidrug resistance (MDR) in cancer: In vitro and in vivoAlbert A De Vera, Pranav Gupta, Zining Lei, et al.
Pageof 67